Nutriband Inc. Common Stock (NTRB)
Stock · NASDAQ · Health Care
$6.21as of 10/16/2026
Price chart
Active signals
NTRB Signal Track Record
How signals performed across all stocks →What NTRB's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 32 | +0.6% | 50% | September 23, 2026 |
| Bollinger Band Breakout | 23 | -1.9% | 39% | September 18, 2026 |
| Bollinger Band Breakdown | 20 | +7.6% | 65% | July 29, 2026 |
| 200-Day Moving Average TouchActive now | 18 | +2.0% | 56% | October 29, 2025 |
| Any 20-session window (baseline) | -4.0% | 42% |
Computed by MarketWall from daily closing prices since July 19, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NTRB
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in…
- Sector
- Health Care
- Industry
- Industrial Specialties
- Website
- nutriband.com/
Fundamentals
- 1-day range
- $6.26$6.8
- Market cap
- $35.43M
- P/E (trailing)
- —
- P/E (forward)
- -27.26
- EPS (trailing)
- $-0.58
- Dividend yield
- —
- Beta
- 2.14
- Avg. volume
- 65.2K
- Dividend pay date
- July 24, 2019
How Nutriband Inc. Common Stock Makes Money
Where the revenue actually goes — FY2026 annual results
Source: 10-K filed Apr 29, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
Nutriband Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- NTRBNutriband Inc. Common Stock$6.22▼ 0.80%Market cap $35.43MP/E —$2.8$9.19
- ADSEWADS-TEC ENERGY PLC Warrant$0.21▼ 4.33%Market cap $38.90MP/E —$0.14$1.37
- MLSSMilestone Scientific Inc. Common Stock$0.33▲ 0.00%Market cap $41.13MP/E —$0.2181$0.5796
- MAMOMassimo Group Common Stock$0.926▼ 0.43%Market cap $44.56MP/E 9.77$0.66$5.59
- LFWDLifeward Ltd. Ordinary Shares$6▼ 0.99%Market cap $20.93MP/E —$4.14$9.84
- MYOMyomo Inc. Common Stock$1.2▼ 7.69%Market cap $50.62MP/E —$0.605$1.89
- COCHEnvoy Medical Inc. Class A Common Stock$0.668▲ 3.57%Market cap $52.34MP/E —$0.3625$0.9539
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NTRB Nutriband Inc. Common Stock | $35.43M | — | $6.22 | ▼ 0.80% | $2.8$9.19 |
| ADSEW ADS-TEC ENERGY PLC Warrant | $38.90M | — | $0.21 | ▼ 4.33% | $0.14$1.37 |
| MLSS Milestone Scientific Inc. Common Stock | $41.13M | — | $0.33 | ▲ 0.00% | $0.2181$0.5796 |
| MAMO Massimo Group Common Stock | $44.56M | 9.77 | $0.926 | ▼ 0.43% | $0.66$5.59 |
| LFWD Lifeward Ltd. Ordinary Shares | $20.93M | — | $6 | ▼ 0.99% | $4.14$9.84 |
| MYO Myomo Inc. Common Stock | $50.62M | — | $1.2 | ▼ 7.69% | $0.605$1.89 |
| COCH Envoy Medical Inc. Class A Common Stock | $52.34M | — | $0.668 | ▲ 3.57% | $0.3625$0.9539 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Nutriband Files U.S. Patent Application To Increase Protection For Its AVERSA Abuse Deterrent Transdermal Technologybenzinga · 10/8/2026
- Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent TechnologyYahoo · 10/8/2026
- Nutriband Files U.S. Patent Application To Increase Protection For Its AVERSA Abuse Deterrent Transdermal TechnologyBenzinga · 10/8/2026
- Nutriband Marks Five Years on Nasdaq – CEO Letter to ShareholdersYahoo · 10/1/2026
- Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid CrisisYahoo · 9/29/2026
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga · 9/28/2026
- Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving PremarketBenzinga · 9/28/2026
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · 9/25/2026
- Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory BoardYahoo · 9/25/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 346.4K
- Total value held
- $1.22M
- Institutional holders
- 12
- Unknown174.9K
- Unknown70.1K
- Unknown32.7K
- Unknown25.0K
- Unknown13.9K
- Unknown11.4K
- Unknown9.5K
- Unknown4.9K
- Unknown2.6K
- Unknown1.0K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Nutriband CEO Featured in Opioid Crisis Documentary; New Advisory Board Member
Nutriband’s chief executive, Gareth Sheridan, was highlighted in a new documentary that examines the opioid crisis, drawing attention to the company’s focus on pain management. The firm also added former Navy SEAL Robert J. O’Neill to its advisory board, adding veteran health expertise. These moves may increase visibility among healthcare investors, as the stock was among several health‑care names moving in recent pre‑market sessions.
Nutriband CEO Featured in Opioid Crisis Documentary; New Advisory Board Member. Nutriband’s chief executive, Gareth Sheridan, was highlighted in a new documentary that examines the opioid crisis, drawing attention to the company’s focus on pain management. The firm also added former Navy SEAL Robert J. O’Neill to its advisory board, adding veteran health expertise. These moves may increase visibility among healthcare investors, as the stock was among several health‑care names moving in recent pre‑market sessions.